These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7198992)

  • 1. Opposed stages of continuous amphetamine administration: parallel alterations in motor stereotypies and in vivo spiroperidol accumulation.
    Ellison G; Morris W
    Eur J Pharmacol; 1981 Sep; 74(2-3):207-14. PubMed ID: 7198992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chronic phencyclidine or d-amphetamine treatment on [3H]spiroperidol binding in rat caudate-putamen and nucleus accumbens.
    Daiguji M; Meltzer HY
    Eur J Pharmacol; 1982 Dec; 85(3-4):339-42. PubMed ID: 7151875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic administration of D-amphetamine increases [3H]spiroperidol binding in cat brain.
    Trulson ME; Crisp T
    Eur J Pharmacol; 1985 Nov; 117(2):267-70. PubMed ID: 4076345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine receptor sensitivity after chronic dopamine agonists. Striatal 3H-spiroperidol binding in mice after chronic administration of high doses of apomorphine, N-n-propylnorapomorphine and dextroamphetamine.
    Riffee WH; Wilcox RE; Vaughn DM; Smith RV
    Psychopharmacology (Berl); 1982; 77(2):146-9. PubMed ID: 6812131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding.
    Sibley DR; Weinberger S; Segal DS; Creese I
    Experientia; 1982 Oct; 38(10):1224-5. PubMed ID: 6890464
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems.
    Robertson HA
    Brain Res; 1983 May; 267(1):179-82. PubMed ID: 6860944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased in vivo [3H]spiroperidol binding in rat brain after repeated methamphetamine administration.
    Kaneno S; Shimazono Y
    Eur J Pharmacol; 1981 Jun; 72(1):101-5. PubMed ID: 7196335
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of haloperidol and d-amphetamine on in vivo 3H-spiroperiodol binding in the rat forebrain(1).
    Saelens JK; Simke JP; Neale SE; Weeks BJ; Selwyn M
    Arch Int Pharmacodyn Ther; 1980 Jul; 246(1):98-107. PubMed ID: 7447553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The late stage following continuous amphetamine administration to rats is correlated with altered dopamine but not serotonin metabolism.
    Ellison G; Ratan R
    Life Sci; 1982 Aug; 31(8):771-7. PubMed ID: 7132578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotyped behavior and diabetes mellitus in rats: reduced behavioral effects of amphetamine and apomorphine and reduced in vivo brain binding of [3H]spiroperidol.
    Rowland N; Joyce JN; Bellush LL
    Behav Neurosci; 1985 Oct; 99(5):831-41. PubMed ID: 3916385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain locations controlling the behavioral effects of chronic amphetamine intoxication.
    Hitzemann R; Wu J; Hom D; Loh H
    Psychopharmacology (Berl); 1980; 72(1):93-101. PubMed ID: 6162168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of naloxone on d-amphetamine- and apomorphine-induced behavior.
    Hitzemann R; Curell J; Hom D; Loh H
    Neuropharmacology; 1982 Oct; 21(10):1005-11. PubMed ID: 6890635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic lithium administration alters behavioral recovery from nigrostriatal injury: effects on neostriatal [3H]spiroperidol binding sites.
    Kozlowski MR; Neve KA; Grisham JE; Marshall JF
    Brain Res; 1983 May; 267(2):301-11. PubMed ID: 6409351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term d-amphetamine in rats: lack of change in post-synaptic dopamine receptor sensitivity.
    Jackson DM; Bailey RC; Christie MJ; Crisp CA; Skerritt JH
    Psychopharmacology (Berl); 1981; 73(3):276-80. PubMed ID: 6787649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased spiroperidol and LSD binding in rat brain after continuous amphetamine.
    Nielsen EB; Nielsen M; Ellison G; Braestrup C
    Eur J Pharmacol; 1980 Aug; 66(2-3):149-54. PubMed ID: 7439269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. d-Amphetamine-induced anorexia and motor behavior after chronic treatment in rats: relationship with changes in the number of catecholamine receptor sites in the brain.
    Bendotti C; Borsini F; Cotecchia S; De Blasi A; Mennini T; Samanin R
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):36-49. PubMed ID: 6962686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased brain dopamine synthesis rate and increased [3H]spiroperidol binding in streptozotocin-diabetic rats.
    Trulson ME; Himmel CD
    J Neurochem; 1983 May; 40(5):1456-9. PubMed ID: 6403671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic phencyclidine, like amphetamine, produces a decrease in [3H]spiroperidol binding in rat striatum.
    Robertson HA
    Eur J Pharmacol; 1982 Mar; 78(3):363-5. PubMed ID: 7067731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic haloperidol on caudate 3H-spiroperidol binding in lesioned rats.
    Rosenblatt JE; Shore D; Neckers LM; Perlow MJ; Freed WJ; Wyatt RJ
    Eur J Pharmacol; 1979 Dec; 60(4):387-8. PubMed ID: 93551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.